Cindy C. Taylor

1.8k total citations
40 papers, 1.4k citations indexed

About

Cindy C. Taylor is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Cindy C. Taylor has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 6 papers in Clinical Psychology. Recurrent topics in Cindy C. Taylor's work include Schizophrenia research and treatment (24 papers), Electroconvulsive Therapy Studies (9 papers) and Bipolar Disorder and Treatment (7 papers). Cindy C. Taylor is often cited by papers focused on Schizophrenia research and treatment (24 papers), Electroconvulsive Therapy Studies (9 papers) and Bipolar Disorder and Treatment (7 papers). Cindy C. Taylor collaborates with scholars based in United States, United Kingdom and Australia. Cindy C. Taylor's co-authors include Bruce J. Kinon, Alan Breier, S.R. David, Gary D. Tollefson, Keith Szymanski, J. A. Gilmore, Bruce R. Basson, Virginia K. Sutton, Karena Meehan and Martín Dossenbach and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Cindy C. Taylor

39 papers receiving 1.4k citations

Peers

Cindy C. Taylor
Steven J. Romano United States
Robert A. Leadbetter United States
Martín Dossenbach United States
Chris Bushe United Kingdom
Jae Seung Chang South Korea
Г. Ингенито United States
Andrew Greenspan United States
Jambur Ananth United States
Steven J. Romano United States
Cindy C. Taylor
Citations per year, relative to Cindy C. Taylor Cindy C. Taylor (= 1×) peers Steven J. Romano

Countries citing papers authored by Cindy C. Taylor

Since Specialization
Citations

This map shows the geographic impact of Cindy C. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy C. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy C. Taylor more than expected).

Fields of papers citing papers by Cindy C. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy C. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy C. Taylor. The network helps show where Cindy C. Taylor may publish in the future.

Co-authorship network of co-authors of Cindy C. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy C. Taylor. A scholar is included among the top collaborators of Cindy C. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy C. Taylor. Cindy C. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lauriello, John, Tim Lambert, Scott W. Andersen, et al.. (2008). An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of Clinical Psychiatry. 69(5). 790–799. 97 indexed citations
2.
Beasley, Charles M., Virginia L. Stauffer, Hong Liu‐Seifert, et al.. (2007). All-Cause Treatment Discontinuation in Schizophrenia During Treatment With Olanzapine Relative to Other Antipsychotics. Journal of Clinical Psychopharmacology. 27(3). 252–258. 35 indexed citations
3.
Mamo, David C., Shitij Kapur, Matcheri S. Keshavan, et al.. (2007). D2 Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia. Neuropsychopharmacology. 33(2). 298–304. 53 indexed citations
4.
Beasley, Charles M., Virginia K. Sutton, Cindy C. Taylor, et al.. (2006). Is Quality of Life Among Minimally Symptomatic Patients With Schizophrenia Better Following Withdrawal or Continuation of Antipsychotic Treatment?. Journal of Clinical Psychopharmacology. 26(1). 40–44. 12 indexed citations
5.
Riesenberg, Robert, Darcie L. Kurtz, Thomas A. Hardy, et al.. (2006). A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects. Clinical Therapeutics. 28(6). 881–892. 19 indexed citations
6.
Hardy, Thomas A., et al.. (2006). Cross-sectional Comparison of Fasting Lipids in Normoglycemic Patients With Schizophrenia During Chronic Treatment With Olanzapine, Risperidone, or Typical Antipsychotics. Journal of Clinical Psychopharmacology. 26(4). 405–408. 15 indexed citations
7.
Wright, Pádraig, Karena Meehan, Martin Birkett, et al.. (2003). A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clinical Therapeutics. 25(5). 1420–1428. 40 indexed citations
8.
Beasley, Charles M., Virginia K. Sutton, S.H. Hamilton, et al.. (2003). A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse. Journal of Clinical Psychopharmacology. 23(6). 582–594. 76 indexed citations
10.
Lindborg, Stacy, Charles M. Beasley, Karla Alaka, & Cindy C. Taylor. (2003). Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. Psychiatry Research. 119(1-2). 113–123. 35 indexed citations
11.
Breier, Alan, Karena Meehan, Martin Birkett, et al.. (2002). A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia. Archives of General Psychiatry. 59(5). 441–441. 207 indexed citations
12.
Chue, Pierre, B. Jones, Cindy C. Taylor, & R. A. Dickson. (2002). Dissolution Profile, Tolerability, and Acceptability of the Orally Disintegrating Olanzapine Tablet in Patients with Schizophrenia. The Canadian Journal of Psychiatry. 47(8). 771–774. 24 indexed citations
13.
Mazzotti, Guido, Wagner F. Gattaz, Jorge Ospina, et al.. (2001). Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America. Journal of Clinical Psychopharmacology. 21(4). 375–381. 31 indexed citations
14.
Tohen, Mauricio, Fan Zhang, Cindy C. Taylor, et al.. (2001). A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. Journal of Affective Disorders. 65(1). 85–93. 49 indexed citations
15.
David, S.R., Cindy C. Taylor, Bruce J. Kinon, & Alan Breier. (2000). The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clinical Therapeutics. 22(9). 1085–1096. 182 indexed citations
16.
David, S.R., Karena Meehan, Virginia K. Sutton, & Cindy C. Taylor. (2000). Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents. Schizophrenia Research. 41(1). 38–39. 6 indexed citations
17.
Meehan, Karena, S.R. David, Cindy C. Taylor, & Virginia K. Sutton. (2000). Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents. Schizophrenia Research. 41(1). 192–192. 6 indexed citations
18.
Taylor, Cindy C., et al.. (1997). Morphine Stimulates Adrenocorticotropin and Cortisol Release in the Late-Term Ovine Fetus. Pediatric Research. 41(3). 411–415. 12 indexed citations
19.
Taylor, Cindy C., et al.. (1996). Differential Mechanisms of Ovine Fetal Pituitary Stimulation by a Selective κ-Opioid Agonist and by Dynorphin. Neuroendocrinology. 64(6). 419–424. 6 indexed citations
20.
Szeto, Hazel H., et al.. (1996). Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus. European Journal of Pharmacology. 297(1-2). 77–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026